10069 Results for "

Against

" in MedChemExpress (MCE) Product Catalog:
Products (10069)

10069 Results for "Against" in MCE Product Catalog:

208
208 Cited Publications
Art. -Nr.: HY-15772
CAS. Nr.: 1421373-65-0
Reinheit:  99.92%
Synonyms: AZD-9291; Mereletinib
Target:  

EGFR

Forschungsgebiete:  

Cancer

Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
208
208 Cited Publications
Art. -Nr.: HY-15772A
CAS. Nr.: 1421373-66-1
Reinheit:  99.97%
Synonyms: AZD-9291 mesylate; Mereletinib mesylate
Target:  

EGFR

Forschungsgebiete:  

Cancer

Osimertinib mesylate (AZD9291 mesylate) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
208
208 Cited Publications
Art. -Nr.: HY-79077
CAS. Nr.: 2070014-82-1
Synonyms: AZD-9291 dimesylate; Mereletinib dimesylate
Target:  

EGFR

Forschungsgebiete:  

Cancer

Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFR L858R and EGFR L858R/T790M, respectively.
loading...
    loading...
207
207 Cited Publications
Art. -Nr.: HY-17364
CAS. Nr.: 85622-93-1
Synonyms: NSC 362856; CCRG 81045; TMZ
Forschungsgebiete:  

Cancer

Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects .
loading...
    loading...
178
178 Cited Publications
Art. -Nr.: HY-B2176
CAS. Nr.: 56-65-5
Synonyms: Adenosine 5'-triphosphate
ATP (Adenosine 5'-triphosphate) is a central component of energy storage and metabolism in vivo. ATP provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP is an important endogenous signaling molecule in immunity and inflammation. ATP can activate the NLRP3 inflammasome and induce IL-1β and chemokines secretion. ATP has anti-bacterial infection effects and can protect mice against bacterial infection in mice .
loading...
    loading...
165
165 Cited Publications
Art. -Nr.: HY-100116A
CAS. Nr.: 845959-50-4
Reinheit:  99.09%
Synonyms: MitoQ mesylate; MitoQ10 mesylate
Forschungsgebiete:  

Metabolic Disease Cancer

Mitoquinone mesylate is a TPP-based, mitochondrially targeted antioxidant in order to protect against oxidative damage .
loading...
    loading...
161
161 Cited Publications
Art. -Nr.: HY-10254
CAS. Nr.: 391210-10-9
Reinheit:  99.95%
Synonyms: PD0325901; PD325901
Target:  

MEK Autophagy Apoptosis

Forschungsgebiete:  

Cancer

Mirdametinib (PD0325901) is an orally active, selective and non-ATP-competitive MEK inhibitor with an IC50 of 0.33 nM. Mirdametinib exhibits a Ki app of 1 nM against activated MEK1 and MEK2. Mirdametinib suppresses the expression of p-ERK1/2 and induces apoptosis. Mirdametinib has anti-cancer activity for a broad spectrum of human tumor xenografts .
loading...
    loading...
161
161 Cited Publications
Art. -Nr.: HY-10087A1
CAS. Nr.: 1093851-28-5
Synonyms: ABT-263 dihydrochloride
Navitoclax dihydrochloride (ABT-263 dihydrochloride) is an orally active BH3 mimetic and an inhibitor of Bcl-2, Bcl-xL, and Bcl-w, with a Ki value of <1 nM for each target. Navitoclax dihydrochloride triggers endogenous Apoptosis and downregulates the expression of Survivin and TGFβ2. Navitoclax dihydrochloride alleviates fibrosis and induces thrombocytopenia. Navitoclax dihydrochloride exhibits anticancer activity against a variety of tumors and enhances the efficacy of chemotherapy and radiotherapy. Navitoclax dihydrochloride can be used in the research of acute lymphoblastic leukemia, ovarian cancer, and fibrotic diseases .
loading...
    loading...
144
144 Cited Publications
Art. -Nr.: HY-10432A
CAS. Nr.: 2828431-89-4
Reinheit:  98.43%
Forschungsgebiete:  

Cancer

A 83-01 sodium is a potent inhibitor of TGF-β type I receptor ALK5 kinase, ALK4 and ALK7, with IC50s of 12 nM, 45 nM and 7.5 nM against the transcription induced by ALK5, ALK4 and ALK7, respectively .
loading...
    loading...
144
144 Cited Publications
Art. -Nr.: HY-10432
CAS. Nr.: 909910-43-6
Reinheit:  99.33%
Forschungsgebiete:  

Cancer

A 83-01 is a potent inhibitor of TGF-β type I receptor ALK5 kinase, type I nodal receptor ALK4 and type I nodal receptor ALK7, with IC50s of 12 nM, 45 nM and 7.5 nM against the transcription induced by ALK5, ALK4 and ALK7, respectively .
loading...
    loading...
138
138 Cited Publications
Art. -Nr.: HY-N0005
CAS. Nr.: 458-37-7
Synonyms: Diferuloylmethane; Natural Yellow 3; Turmeric yellow
Curcumin (Diferuloylmethane), a natural phenolic compound, is a p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. Curcumin is a photosensitizer against microorganisms. Curcumin shows inhibitory effects on NF-κB and MAPKs, and has diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification.
loading...
    loading...
131
131 Cited Publications
Art. -Nr.: HY-100489
CAS. Nr.: 1948-33-0
Reinheit:  99.89%
Synonyms: tert-Butylhydroquinone
TBHQ (tert-Butylhydroquinone) is a widely used Nrf2 activator, protects against Doxorubicin (DOX)-induced cardiotoxicity through activation of Nrf2 . TBHQ (tert-Butylhydroquinone) is also an ERK activator; rescues Dehydrocorydaline (DHC)-induced cell proliferation inhibitionin melanoma .
loading...
    loading...
106
106 Cited Publications
Art. -Nr.: HY-13605A
CAS. Nr.: 69-74-9
Reinheit:  99.67%
Synonyms: Cytosine β-D-arabinofuranoside hydrochloride; Cytosine Arabinoside hydrochloride; Ara-C hydrochloride
Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV.
loading...
    loading...
106
106 Cited Publications
Art. -Nr.: HY-13605
CAS. Nr.: 147-94-4
Reinheit:  99.98%
Synonyms: Cytosine β-D-arabinofuranoside; Cytosine Arabinoside; Ara-C
Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity.
loading...
    loading...
102
102 Cited Publications
Art. -Nr.: HY-K1006

MCE Penicillin-Streptomycin (100×), Sterile is used to prevent bacterial contamination of cell culture due to their effective combined action against gram-positive and gram-negative bacteria, which contains 10,000 units/mL of penicillin and 10 mg/mL of streptomycin.

loading...
    loading...
102
102 Cited Publications
Art. -Nr.: HY-P1061
CAS. Nr.: 867021-83-8
Target:  

STAT Amyloid-β

Forschungsgebiete:  

Neurological Disease

Colivelin is a brain penetrant neuroprotective peptide and a potent activator of STAT3, suppresses neuronal death by activating STAT3 in vitro . Colivelin exhibits long-term beneficial effects against neurotoxicity, Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease . Colivelin has the potential for the treatment of alzheimer's disease and ischemic brain injury
loading...
    loading...
102
102 Cited Publications
Art. -Nr.: HY-P1061A
CAS. Nr.: 2803948-60-7
Target:  

STAT Amyloid-β Apoptosis

Forschungsgebiete:  

Neurological Disease

Colivelin TFA is a brain penetrant neuroprotective peptide and a potent activator of STAT3, suppresses neuronal death by activating STAT3 in vitro . Colivelin TFA exhibits long-term beneficial effects against neurotoxicity, Aβ deposition, neuronal apoptosis, and synaptic plasticity deficits in neurodegenerative disease . Colivelin TFA has the potential for the treatment of alzheimer's disease and ischemic brain injury .
loading...
    loading...
100
100 Cited Publications
Art. -Nr.: HY-50898
CAS. Nr.: 231277-92-2
Synonyms: GW572016; GW2016
Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
100
100 Cited Publications
Art. -Nr.: HY-50898A
CAS. Nr.: 388082-77-7
Synonyms: GW572016 ditosylate; GW2016 ditosylate
Lapatinib ditosylate (GW572016 ditosylate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
100
100 Cited Publications
Art. -Nr.: HY-50898B
CAS. Nr.: 388082-78-8
Synonyms: GW572016 ditosylate monohydrate; GW2016 ditosylate monohydrate
Target:  

EGFR Autophagy Ferroptosis

Forschungsgebiete:  

Infection Metabolic Disease Cancer

Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...